Illustrative output
An action-ready synthesis, not a pile of consultant slides.
The report connects findings to decisions. It makes evidence quality, trade-offs, dependencies, and the post-close agenda visible in one structured view.
Recommended path
Proceed to confirmatory diligence-with three conditions.
The company shows real category pull and strong customer advocacy. The principal risks are enterprise concentration, founder-dependent sales, and weak implementation capacity.
01 Validate top-account renewal exposure
02 Hire an implementation leader
03 Formalise enterprise pipeline governance
Why the thesis can work
High-value workflowClear customer ROI and strong daily product relevance.
Account expansionMeaningful expansion inside mature, well-implemented customers.
Defensible data advantageDomain data compounds product value and customer switching cost.
| Finding | Severity | Evidence confidence | Investment implication |
|---|---|---|---|
| Revenue concentration Two enterprise accounts influence reported retention quality. | High | 86% | Rebuild account-level cohorts and validate renewal exposure. |
| Founder-dependent sales Founder remains involved in most strategic late-stage deals. | High | 91% | Treat repeatability as a condition, not a future aspiration. |
| International channel economics Partner activation and contribution margin are not yet evidenced. | Medium | 43% | Pause expansion until economics and ownership are validated. |
| Product roadmap capacity Customer commitments may crowd out platform work. | Medium | 61% | Confirm delivery capacity and roadmap trade-offs. |
Days 0-30
Stabilise the baseline
- Rebuild account-level retention cohorts
- Define sales qualification and forecast rules
- Recruit implementation leadership
Days 31-60
Reduce dependencies
- Separate founder sponsorship from sales ownership
- Install delivery capacity planning
- Create board-level commercial dashboard
Days 61-90
Test value creation
- Launch pricing and packaging experiment
- Activate mature-account expansion play
- Re-assess thesis-linked dimensions
Observed strengths
- High strategic pattern recognition
- Strong customer credibility
- Complementarity across product and commercial domains
Scaling dependencies
- Founder remains the default escalation path
- Conflict is delayed until decisions become urgent
- Decision rights are not explicit when founders disagree
Practical actions
- Define founder-only versus delegated decisions
- Introduce a conflict and escalation protocol
- Shift the founder to strategic sponsorship, not process ownership
Illustrative only. A real module requires informed consent, validated instruments, qualified interpretation, and an agreed protocol for sensitive information. It is not a clinical diagnosis or a standalone investment verdict.
Make scaling with a clearer view.
Investors can scope a decision assessment. Founders and CEOs can validate priorities, plans, scalability, and investment readiness before outreach or due diligence.